Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-15IMNM144Rosett Max plan to sell securities of Immunome Inc. under Form 144MEDIUM
Rosett Max filed Form 144 to notify SEC of plan to sell 60000 units of Immunome Inc. securities around 2026-06-15, with aggregate market value of $1,117,800.00. The total outstanding units is 113250394.0. The amount planned to be sold represents 0.05% of total outstanding units; Recent transactions in past 3 months inc...
Mid CapBiotechnology
2026-06-15IMVT144Atul Pande plan to sell securities of IMMUNOVANT, INC. under Form 144MEDIUM
Atul Pande filed Form 144 to notify SEC of plan to sell 6000 units of IMMUNOVANT, INC. securities around 2026-06-15, with aggregate market value of $201,720.00. The total outstanding units is 205308917.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months inc...
Mid CapBiotechnology
2026-06-15JAZZ144MARK D SMITH plan to sell securities of JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY under Form 144MEDIUM
MARK D SMITH filed Form 144 to notify SEC of plan to sell 1157 units of JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY securities around 2026-06-15, with aggregate market value of $266,746.35. The total outstanding units is 62742820.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Large CapBiotechnology